| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 10/02/2026 | ±2.9% | -3.6% | under-priced |
| 07/15/2026 | ±3.4% | -0.2% | over-priced |
| 04/01/2026 | ±2.8% | -15.5% | under-priced |
| 12/30/2025 | ±2.6% | -0.0% | over-priced |
| 10/01/2025 | ±2.1% | +6.4% | under-priced |
| 07/17/2025 | ±2.6% | +1.2% | over-priced |
| 04/03/2025 | ±2.8% | -14.4% | under-priced |
| 01/03/2025 | ±2.5% | -0.5% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2027 | $0.48 | $11.2B | $712M |
| Q4 FY2026 | — | $11.0B | $1.1B |
| Q3 FY2026 | $0.35 | $11.3B | $520M |
| Q2 FY2026 | $0.53 | $12.4B | $792M |
NKE (NKE) reports in 66 days, with the next report estimated for 01/01/2027. Across the last 8 reports, options priced an average ±2.7% earnings move while the stock actually moved 5.2% on average — the market has been roughly fair on NKE's earnings risk. Fundamentals into the print: EPS down 2.0% year-over-year, revenue down 4.3%. QuantLogix's live 5-factor engine currently reads NKE as a buy at 61/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →